
Projection of top 2023 pharma and biotech launches by revenue 2028
This statistic depicts the biggest potential biotech and conventional pharmaceutical product launches globally in 2023 and their projected revenues for 2028, as of December 2022. Eisai's and Biogen's probably in 2023 to-be-launched Alzheimer's disease treatment Lecanemab is expected to garner some three billion U.S. dollars in 2028.